ICON Announces Pricing of USD 2.15 Billion Notes

Contributed by: Business Wire

Logo

Tags

Consulting

Biotechnology

Professional Services

Health

General Health

Pharmaceutical

Medical Devices

Research

Science

Clinical Trials

Finance

ICON plc

More Like This

ICON Announces Pricing of USD 2 Billion Notes

ICON Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call and Acknowledges Receipt of Deficiency Notice from Nasdaq

ICON plc Schedules Third Quarter 2024 Earnings Conference Call

ICON plc Schedules First Quarter 2025 Earnings Conference Call

ICON plc Provides Update on Timing of Fourth Quarter and Full Year 2025 Earnings Results and Investigation into Accounting Practices

ICON Hosts Investor Day and Updates Full Year 2024 Financial Guidance

ICON Reports Second Quarter 2024 Results

ICON Provides Update on Audit Committee Investigation and Timing of Fourth Quarter and Full Year 2025 Financial Results